Financhill
Back

Akero Therapeutics Quote, Financials, Valuation and Earnings

Akero Therapeutics Price Quote

$29.35
+0.01 (+3.35%)
(Updated: December 21, 2024 at 5:14 AM ET)

Akero Therapeutics Key Stats

Sell
32
Akero Therapeutics (AKRO) is a Sell

Day range:
$28.09 - $29.77
52-week range:
$15.32 - $37.00
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
2.77%

Volume:
1.6M
Avg. volume:
658K
1-year change:
36.09%
Market cap:
$2B
Revenue:
$0
EPS:
$-3.78

How Much Does Akero Therapeutics Make?

Data Unavailable

Is Akero Therapeutics Growing As A Company?

Data Unavailable

Akero Therapeutics Stock Price Performance

What Is Akero Therapeutics 52-Week High & Low?

Akero Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Akero Therapeutics?

Data Unavailable

Is Akero Therapeutics Cash Flow Positive?

Data Unavailable

Akero Therapeutics Return On Invested Capital

Data Unavailable

Akero Therapeutics Earnings Date & Stock Price

Akero Therapeutics Competitors

  • Who Are Akero Therapeutics's Competitors?
    Below is a list of companies who compete with Akero Therapeutics or are related in some way:
    • 89bio Inc (ETNB)
    • iBio Inc (IBIO)
    • Madrigal Pharmaceuticals Inc (MDGL)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)

Akero Therapeutics Dividend Yield

Data Unavailable

Akero Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -12.36%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 50.00
Upside from Last Price: 70.42%

Major Shareholders

Data Unavailable